Search Results (60)

Objective: Electrocorticography can serve as an intraoperative research tool during deep brain stimulation procedure, when patients are awake to participate in behavioral tasks or to allow recordings while awake but at rest. This report aims to describe the electrocorticography methods used in awake patients undergoing deep brain stimulation surgery at a single center and to describe the feasibility, safety, and usefulness of high-density electrocorticography for capturing high-resolution neurophysiological data during deep brain stimulation surgery. We hypothesize that the use of high-density electrocorticography and multi-subject integration of cortical data enables improved spatial resolution and data analysis compared to prior studies employing lower-density electrodes and primarily single-subject analyses. Methods: Data were obtained from patients undergoing awake deep brain stimulation surgery for the treatment of Parkinson’s disease or essential tremor at Johns Hopkins Hospital between March 2022 and September 2024. Electrophysiological and anatomical data were analyzed, with localization in the anterior commissure and posterior commissure and Montreal Neurological Institute coordinate systems. Surgical complications were monitored for at least six months postoperatively. Results: Thirty-six patients (26 with Parkinson’s disease, 10 with essential tremor) were enrolled in the study. In one case, anatomical placement was inadequate for neurophysiological analysis. Postoperative complications included three infections (8.3%) and one chronic subdural hematoma (2.8%), with no permanent neurological deficits. Observed complication rates were within the range reported in the literature for standard deep brain stimulation surgeries without electrocorticography. Anatomical and neurophysiological analysis demonstrated high-resolution cortical mapping. Multiple-subject level analysis using high-density electrocorticography yielded over 1300 electrode positions. Conclusions: Electrocorticography during deep brain stimulation is a valuable research method for movement disorders and, based on a moderate sized consecutive clinic sample, appears safe with risks no greater than those associated with DBS surgery itself. Full article

Objectives: Frailty, reflecting reduced physiological reserve, has emerged as a predictor of postoperative outcomes in neurosurgery and may provide greater prognostic value than age. In chronic subdural hematoma (cSDH), prospective data remain scarce. This study investigates the association between preoperative frailty, assessed using the Clinical Frailty Scale (CFS), and postoperative recovery in cSDH patients. Methods: In this ongoing prospective single-center cohort study, 78 consecutive patients (≥60 years) with cSDH were enrolled between August 2022 and October 2024. After exclusion of four conservatively managed patients, 74 surgically treated patients were included in the analysis. Frailty was defined as Clinical Frailty Scale (CFS) ≥ 5. The primary outcome was the Glasgow Outcome Scale-Extended at 6 months (GOSE6). Secondary outcomes included GOSE at discharge (GOSE0) and three months (GOSE3), revision surgery, intensive care unit (ICU) admission, and mortality after six months. Results: Higher CFS scores significantly correlated with poorer outcome at 6 months (r = −0.68, p_adj = 0.011). In regression analysis, frailty (p < 0.001), age (p_adj = 0.014), and revision surgery (p_adj = 0.009) were significant predictors of outcome. Frailty was associated with a reduced likelihood of a good neurological outcome (OR = 0.02, 95% CI: [0.004, 0.085]). Frail patients had significantly poorer outcomes at all timepoints (all p_adj = 0.014) and none achieved a favorable outcome (GOSE ≥ 6). Six-month mortality was significantly higher in frail patients compared to non-frail patients (32% vs. 4%, p_adj = 0.048, relative risk RR = 3.29, 95% CI [1.67, 5.78]). Conclusions: Our interim results suggest that preoperative frailty, as measured by the CFS, is strongly associated with poorer neurological recovery and higher mortality following surgical treatment of cSDH. Frailty assessment may facilitate individualized treatment strategies and improve risk stratification beyond age or comorbidity burden. Full article

Background/Objectives: Intracranial hypotension is a rare and underdiagnosed serious condition characterized by low cerebrospinal fluid (CSF) pressure, often resulting from trauma to the dura mater. While manual therapy is increasingly used for musculoskeletal complaints, it is not without risk and may, in rare cases, result in complications such as dural tears. Although these complications are rare, they require early recognition and appropriate treatment to prevent further morbidity. This case report aims to highlight a rare presentation of multilevel dural defects in temporal association with manual therapy and to demonstrate the efficacy of epidural blood patch (EBP) treatment. Case Presentation: We report a case of a 46-year-old woman without chronic illness who developed worsening orthostatic headaches, weakness, and vomiting after multiple manual therapy sessions. Only after 6 months did the patient undergo magnetic resonance imaging (MRI), which revealed intracranial hypotension due to dural damage in the spinal dura mater at C6–T1 and T8–T10, brain sagging, and an increased risk of subdural hematoma. After excluding other causes of dural defects, EBP was performed under CT guidance at C6–C7 and T8–T9, which resulted in symptom regression. Follow-up MRI was recommended for the patient. Conclusions: This case highlights a rare but clinically significant occurrence of multilevel dural defects and intracranial hypotension in temporal association with manual therapy. This emphasizes the critical role of timely diagnosis using MRI and the clinical effectiveness of EBP as a minimally invasive procedure. Full article

Background/Objectives: Chronic subdural hematoma (cSDH) is an increasingly prevalent neurosurgical condition in the aging population. Burr hole craniotomy (BHC) with irrigation and postoperative drainage represents the evidence-based standard of care, yet recurrence rates remain substantial. Twist drill craniostomy (TDC), a minimally invasive bedside procedure performed under local anesthesia, offers theoretical advantages for frail patients but has been largely abandoned due to concerns regarding incomplete evacuation and recurrence. This study aimed to identify the predictors of a successful TDC outcome and to compare the recurrence rates between TDC and BHC. Methods: We performed a retrospective cohort study of consecutive patients undergoing surgical treatment for radiologically confirmed cSDH at RWTH Aachen University Hospital between 2015 and 2023. Hematoma morphology was classified using an extended CT-based architecture system and grouped into homogeneous, organized, sedimented, or subacute categories. The primary endpoint was recurrence requiring surgical reintervention. Multivariable logistic regression was used to identify independent predictors of recurrence among patients discharged after definitive TDC. Propensity score matching was performed to compare recurrence rates between TDC and BHC while adjusting for baseline demographic, clinical, and radiographic differences. Results: Among 178 patients initially treated with TDC, 56 (31.5%) were discharged without conversion to BHC. Late recurrence occurred in 26 of 56 patients (46.4%) treated definitively with TDC. In multivariable analysis, homogeneous hematoma architecture was the only independent predictor of recurrence (adjusted OR 4.48, 95% CI 1.10–22.07, p = 0.037). Propensity score matching yielded 48 well-balanced pairs of TDC and BHC patients. Recurrence rates remained significantly higher after TDC compared with BHC (42.6% vs. 17.0%, p = 0.012), as confirmed by conditional logistic regression (adjusted OR 3.20, 95% CI 1.17–8.73). Conclusions: Twist drill craniostomy may provide definitive treatment in carefully selected patients but is associated with substantially higher recurrence rates than burr hole craniotomy, particularly in homogeneous hematomas. Burr hole evacuation remains the preferred standard approach, while optimized drainage protocols and architecture-guided selection may define a limited role for TDC in high-risk patients. Full article

Introduction: Chronic subdural hematoma (CSDH) is a complex disease with an overall incidence of 1.7–20.6 per 100,000 persons per year and is more commonly encountered in the elderly population. It is projected to be one of the most common neurosurgical procedures. Postoperative delirium is a common complication associated with the elderly, causing increased morbidity and prolonged hospital stay. However, its risk factors in chronic subdural hematoma patients have not been well studied. Methods: A total of 202 consecutive patients with chronic subdural hematoma at different neurosurgical centers in Europe between January 2023 and June 2025 were enrolled. Various clinical indicators were analyzed to identify independent risk factors for postoperative delirium using univariate and multivariate regression analyses. Results: Out of the 202 patients (age, 71 (IQR, 18); female-to-male ratio, 1:2.7) studied, 63 (31.2%) experienced postoperative delirium. Univariate analysis identified age (p < 0.001), gender (p = 0.014), restraint belt use (p < 0.001), electrolyte imbalance (p < 0.001), visual analog scale (VAS) pain score (p < 0.001), hematoma thickness (p < 0.001), midline shift (p < 0.001), hematoma side (p = 0.013), hematoma location (p = 0.018), and urinal catheterization (p = 0.028) as significant factors. Multivariate regression analysis confirmed the significance of restraint belt use (B = 7.657, p < 0.001), electrolyte imbalance (B = −3.993, p = 0.001), VAS pain score (B = 2.331, p = 0.016), and midline shift (B = 0.335, p = 0.007). Hematoma thickness and age had no significant impact. Conclusions: Increased midline shift and VAS pain scores, alongside restraint belt use and electrolyte imbalance, elevate delirium risk in chronic subdural hematoma surgery. Our prediction models may offer a reference value in this context. Full article

Background: Sarcopenia is increasingly recognized as a prognostic factor in surgical populations. This study evaluated the association between cranial CT-based markers of sarcopenia and neurological outcomes in patients undergoing surgery for chronic subdural hematoma (CSDH). Methods: This retrospective case–control study included 82 patients who underwent surgery for unilateral CSDH. Demographic data, comorbidities, use of anticoagulant and antiplatelet therapy, postoperative complications and length of hospital stay were collected from patients’ medical records. Radiological parameters of sarcopenia, including temporal muscle thickness, temporal muscle area, and occipital fat pad thickness, as well as standard radiological features of CSDH, were measured preoperatively on the initial CT scan. Neurological outcome 3 months after surgery was assessed using the Glasgow Outcome Scale, with scores ≥ 4 defined as favourable and scores 1–3 as poor. Results: Demographic and clinical characteristics, including age, sex, comorbidities, hematoma thickness and intracranial midline shift, did not differ significantly between outcome groups. Temporal muscle thickness (4.7 vs. 2.8 mm, p < 0.001), temporal muscle area (160 vs. 106 mm², p = 0.04), and occipital fat pad thickness (4.7 vs. 3.4 mm, p = 0.04) were significantly greater in patients with favourable neurological outcomes. After corrections for age and comorbidities, multivariate logistic regression with temporal muscle thickness, area and density, temporal bone thickness and density, and occipital fat pad thickness demonstrated that temporal muscle thickness was the only independent predictor of good neurological recovery (OR 3.20, 95% CI 1.37–7.46, p = 0.007). ROC analysis showed good discriminatory power of temporal muscle thickness (AUC 0.812, 95% CI 0.695–0.930, p < 0.001), with a cut-off value of ≥3.37 mm for its ability to predict favourable neurological outcome. Conclusions: Temporal muscle thickness is a reliable, non-invasive imaging biomarker for predicting good neurological recovery after CSDH surgery and may aid in risk stratification, particularly in elderly or frail patients. Full article

Accurate identification of acute and subacute subdural hematoma (acute/subacute SDH) is critical for improved patient outcomes. However, large-scale research is hindered by unreliable identification methods in electronic health records (EHRs). Current approaches relying on International Classification of Diseases (ICD) codes lack specificity and cannot distinguish acute, subacute, and chronic cases; manual chart review is too labor-intensive to scale. We developed an automated phenotyping algorithm using structured data and unstructured clinical notes for high-accuracy retrospective identification of acute/subacute SDH. We analyzed 2999 records from two hospitals, including ICD-positive and ICD-negative acute/subacute SDH cases verified by manual chart review. Features for model training included ICD codes, Current Procedural Terminology (CPT) codes, and clinical note keywords. Logistic regression and random forest models were trained using cross-validation and evaluated using AUROC and AUPRC. External validation involved training on one hospital and testing on the other. The random forest keywords-only model performed best, achieving an AUROC of 0.985 (95% CI: 0.980–0.990) and AUPRC of 0.944 (95% CI: 0.923–0.962) on the test set. External validation demonstrated strong AUROCs of 0.965 and 0.971 and AUPRCs of 0.831 and 0.840. The overall error rate was <1%. This model provides a scalable, highly accurate approach to acute/subacute SDH detection in EHR research. Full article

Objective: Chronic subdural hematoma (cSDH) is a common neurosurgical condition with rising incidence in the aging population. Recurrence after surgical evacuation remains frequent, affecting up to one third of patients. Prior studies have proposed an association between ABO blood type and recurrence risk, though the findings are inconsistent. This study aimed to determine whether ABO blood group independently predicts cSDH recurrence after adjusting for clinical and radiological risk factors and to contextualize these findings in the context of previously published studies. Methods: We conducted a retrospective cohort study of all consecutive patients surgically treated for cSDH at University Hospital RWTH Aachen between 2015 and 2023. Clinical, laboratory, and imaging data, including hematoma volume, laterality, and architecture, were extracted from medical records. The primary outcome was recurrence requiring reintervention. Associations between ABO blood type and recurrence were assessed using chi-square tests and multivariable logistic regression. A random-effects meta-analysis was performed to integrate our findings with all identified prior studies reporting recurrence stratified by blood type. Results: Of 630 treated patients, 488 with documented ABO blood type and recurrence status were included. Recurrence occurred in 31.1% of these patients. ABO distribution matched European population frequencies. Univariate analysis showed no association between blood type and recurrence (p = 0.434). Adjusted models likewise showed no significant differences between type A and type B (OR 1.43, 95% CI 0.67–3.00), type AB (OR 2.35, 95% CI 0.74–7.24), and type O (OR 0.95, 95% CI 0.57–1.58). Hematoma architecture remained strongly associated with recurrence (p < 0.001). A meta-analysis of available studies similarly demonstrated no association between any ABO blood type and recurrence, with pooled odds ratios near unity across comparisons. Conclusions: ABO blood type was not associated with cSDH recurrence in our cohort, and pooled evidence from previously published studies confirms the absence of a meaningful effect. Hematoma architecture and volume remain the most important predictors of recurrence. Based on these results, blood type should not influence postoperative surveillance or counseling, and future work should focus on modifiable biological and imaging-based determinants of recurrence. Full article

Background: Antithrombotic therapy is a risk factor for subdural hematoma after head injury. Methods: We retrospectively studied 180 consecutive patients with traumatic acute subdural hematoma. Results: The median age was 81 years, 68 (38%) were female, and 44% were on antithrombotic therapy. In the antithrombotic therapy group, the patients were significantly older (84, 77–88 vs. 78, 74–84, p value = 0.00104), and the proportion of minor injury was significantly higher (83% vs. 61%, p value = 0.00178). Poor clinical outcomes were not significantly different between the groups (44% vs. 41%; p value = 0.762). In multivariable logistic regression analysis adjusted for age and sex, poor outcomes (42%) were associated with the first Glasgow coma scale scores (OR 0.73, 95% CI 0.65–0.82, p value < 0.001) and the first CT findings (OR 4.9, 95% CI 1.98–11.8, p value < 0.001), but not with antithrombotic therapy (OR 1.48, 95% CI 0.61–3.60, p value = 0.390). Of the 97 patients treated conservatively for more than 2 weeks, surgical intervention in the chronic phase was higher in the antithrombotic therapy group (16% vs. 1.9%; p value = 0.0230). The timing of re-administration did not correlate with the incidence of chronic surgical intervention (within 2 weeks: 18%; over 2 weeks: 9.1%; p value = 0.663). Conclusions: The proportion of minor injury was significantly higher in the antithrombotic therapy group than in the non-medication group. Antithrombotic therapy was not associated with poor outcome but correlated with the increased risk of surgical intervention in the chronic phase. Full article

Background: Chronic subdural hematoma is commonly managed with surgical evacuation when significant mass effect or herniation features are present. Although middle meningeal artery embolization has emerged as an effective adjunctive therapy, evidence supporting its use as standalone treatment in patients with radiological herniation remains limited. Case Presentation: We report a 51-year-old man who presented with a three-week history of progressive headache, intermittent confusion, and mild left-sided weakness. Magnetic resonance imaging demonstrated a right-sided chronic subdural hematoma with marked cortical compression and subfalcine herniation. Despite radiological severity, the patient remained neurologically stable. After multidisciplinary discussion, middle meningeal artery embolization was performed as sole therapy via right radial access using a liquid embolic agent. Selective angiography demonstrated pathological neovascular supply from the right middle meningeal artery, which was completely obliterated following embolization without procedural complications. The post-procedural course was uneventful, with progressive clinical improvement. Follow-up non-contrast computed tomography at eight months demonstrated near-complete resolution of the hematoma with normalization of midline structures, and no surgical evacuation was required. Conclusions: Standalone middle meningeal artery embolization may represent a feasible therapeutic option in carefully selected clinically stable patients with chronic subdural hematoma and radiological herniation features, though further studies are required to define optimal selection criteria and long-term outcomes. Full article

Background: IgG4-related hypertrophic pachymeningitis (IgG4-RHP) is an extremely rare central nervous system (CNS) autoimmune disorder, characterized by dural thickening, space-occupying effects, and neurological compression symptoms. It is frequently misdiagnosed as meningioma due to overlapping radiological features, leading to inappropriate management. This study aims to report a unique case of IgG4-RHP with skull destruction and subcutaneous mass formation, and summarize its diagnostic and therapeutic strategies through literature review. Methods: A 53-year-old male with a chronic subdural hematoma history was admitted for a progressive right frontal subcutaneous mass. Preoperative computed tomography (CT) and magnetic resonance imaging (MRI) were performed, followed by staged surgeries (subcutaneous biopsy and craniotomy with subtotal resection). Histopathological examinations (Hematoxylin and Eosin staining, IgG/IgG4 immunostaining) and serum IgG4 detection were conducted. The patient received postoperative prednisone acetate (60 mg/d) and 3-month follow-up. A literature search was also performed to analyze 34 previously reported IgG4-RHP cases. Results: Histopathology showed dense lymphoplasmacytic infiltration, storiform fibrosis, ≈40 IgG4+ plasma cells per high-power field (HPF), and an IgG4+/IgG+ ratio of ≈30%. Serum IgG4 was significantly elevated to 1521 μg/mL (normal < 1350 μg/mL), with marked reduction in residual lesions on follow-up MRI. Literature review revealed a 73.5% male predominance, mean age of 48.6 years, headache as the most common symptom (58.8%), and a 38.5% misdiagnosis rate. Glucocorticoids alone or combined with immunosuppressants achieved favorable outcomes in 96.0% of treated cases. Conclusions: Histopathological examination combined with serum IgG4 detection is the gold standard for IgG4-RHP diagnosis. Surgical resection relieves mass-occupying effects, while glucocorticoids are first-line therapy. Long-term follow-up is necessary for recurrence monitoring, and rituximab is effective for refractory cases. Awareness of atypical manifestations like skull destruction can reduce misdiagnosis and improve outcomes. Full article

Chronic subdural hematoma (CSDH) in frail older adults is increasingly recognized as a sentinel event, with mortality often driven by medical complications rather than neurosurgical factors. We report a failure-to-rescue case in which rapid postoperative deterioration occurred after burr-hole drainage for bilateral CSDH in a frail older adult with diabetes. A clinical picture consistent with sepsis was suspected, and a gastrointestinal source was considered, but the infectious focus could not be confirmed due to limited diagnostic work-up. On admission, chest-computed tomography showed mild right lower-lobe pneumonia, and incidental transverse colonic dilatation was also visible. Burr-hole drainage was uneventful and oxygenation rapidly normalized on room air. On postoperative day (POD) 3, the patient developed a high fever (39 °C), rising C-reactive protein (CRP; 14 mg/dL), abrupt leukopenia (15,300 → 3300/µL), and, several hours later, profuse watery diarrhea. At that time, an evaluation for an infectious source and escalation of therapy (e.g., blood cultures, serum lactate, and abdominal imaging) were not performed. In the early hours of POD 4, he suffered sudden desaturation, shock, and cardiac arrest, and died despite resuscitation. A portable radiograph after intubation showed no new diffuse pulmonary infiltrates but marked colonic gas distension. This case highlights the need to reassess diagnostic framing when discordant postoperative “red flags” emerge and proposes practical triggers for early sepsis evaluation and escalation—prioritizing early recognition and timely rescue rather than a definitive determination of the cause of death—in high-risk CSDH patients. Full article

Cerebral Amyloid Angiopathy (CAA) is a neurovascular condition characterized by the accumulation of amyloid-beta (Aβ) in the walls of small blood vessels, particularly affecting the leptomeninges and cortical regions in elderly populations. Initially recognized for its association with spontaneous lobar intracerebral hemorrhage, recent studies have highlighted the broader implications of CAA on cognitive decline and vascular health. This narrative review aims to elucidate the mechanisms of dural involvement in CAA, an aspect that has been largely overlooked in existing literature. This paper provides a detailed examination of the potential role of the dura mater and its associated lymphatic system in the clearance of interstitial amyloid and the maintenance of cerebrospinal fluid (CSF) homeostasis. Dural lymphatic vessels may facilitate the efflux of Aβ from the brain, and any impairment in this drainage system could contribute to the pathological accumulation of amyloid, exacerbating CAA and its neurological consequences. Additionally, the significant association between CAA and subdural hematoma (SDH) has been explored, indicating that the presence of SDH may complicate the clinical management of CAA patients by signaling an increased risk of hemorrhagic events. The mechanisms linking CAA and SDH, including vascular fragility and chronic inflammatory processes, are discussed to provide insight into potential pathways for therapeutic intervention. Full article

Background: Accurate volumetry and imaging characterization of chronic subdural hematoma (cSDH) are essential for prognostication and treatment planning, but manual assessment is time-consuming and therefore underutilized. Methods: We retrospectively analyzed preoperative non-contrast CT (NCCT) scans of 257 patients undergoing first-time surgery for uni- or bilateral cSDH. Hematoma volumes were measured manually using a semi-automated area-outlining tool on every second axial slice and compared with the volumes estimated through the ABC/2 formula. Hematoma attenuation patterns and components were categorized, and interrater reliability was assessed for volume, maximum diameter, and imaging features using intraclass correlation coefficients (ICCs) and Cohen’s κ. Results: A total of 339 hematomas were evaluated. Manual and ABC/2 volume measurements correlated strongly (R² = 0.83, ICC [3, 1] = 0.90). The interrater agreement for manual volumetry was excellent (ICC [2, 1] = 0.96). Agreement was also excellent for maximum diameter (ICC [2, 1] > 0.9) and good for midline shift assessment (κ = 0.81). Agreement was moderate for the identification of fresh clots, trabeculations, and laminations (κ = 0.62–0.72) but poor for general attenuation patterns (κ = 0.44). Conclusions: The manual volumetry of cSDH is feasible and highly reproducible between raters of different experience levels. These results provide a robust reference standard for the validation of automated volumetry tools and support the implementation of quantitative hematoma assessment in future clinical trials and routine care. Full article

Background: Moyamoya syndrome is a moyamoya-like cerebrovascular condition associated with an identifiable underlying condition. Although head trauma has historically been considered a possible contributing factor, it is currently excluded from the Japanese diagnostic criteria. We report a rare case of progressive unilateral moyamoya-like vasculopathy that developed on the ipsilateral chronic subdural hematoma (CSDH) following head trauma, with a decade-long imaging follow-up. Anterior circulation basi-parallel anatomical scanning (BPAS) provided unique insights into the progressive vessel narrowing beyond the vascular lumen, suggesting its potential utility in evaluating such rare vasculopathies. Case Presentation: A 40-year-old man developed a left-sided CSDH after head trauma and underwent burr hole drainage. Although his symptoms resolved, serial magnetic resonance angiography (MRA) over the subsequent 10 years revealed progressive stenosis of the left middle cerebral artery (MCA), ultimately culminating in an occlusion-like appearance. BPAS revealed moyamoya-like collateral vessels in the same hemisphere, a significant reduction in the outer diameter of the left MCA, supporting the presence of structural arterial wall changes that were not apparent on conventional MRA. Single-photon emission computed tomography revealed mildly reduced cerebral blood flow on the affected side, with a difference of less than 5% compared to non-affected side. He remained neurologically non-symptomatic, with no history of transient ischemic attacks or overt ischemic stroke. Conclusions: This case highlights a rare clinical course of progressive ipsilateral moyamoya-like vascular changes following head trauma and burr-hole drainage for CSDH, potentially indicating an association between head trauma, CSDH, and subsequent moyamoya-like collateral vessel development, warranting further investigation. The use of the anterior circulation BPAS contributed to the detection of structural arterial changes that were not apparent on conventional MRA, suggesting its potential utility in evaluating such vascular abnormalities. Full article